EMA launches new catalogs for real-world data and studies

The European Medicines Agency (EMA) recently launched the HMA-EMA catalogues for Real-World Data (RWD), which serve as comprehensive repositories for metadata from RWD sources and studies. These catalogs replace and expand the previous EU PAS Register® and EncePP Resource Database databases. They cover four main areas: data sources (238), studies (2976), institutions (770) and networks (178).

The aim of these catalogs is to help regulators, pharmaceutical companies, and researchers identify and use data to study the use, safety, and effectiveness of drugs. The catalogues are used to find suitable data sources, to evaluate the suitability of data sources, to improve interoperability between studies and data sources and to increase transparency. The EMA is currently (until 17.1.2025) carrying out a survey on the usability of the catalogues in order to further improve the system. For data owners, there are special instructions on how to access their previously published data sets in the new catalogs.

This initiative can lead to improved transparency and efficiency in medical research. Your success depends on the extent to which users can benefit from this.

Source and detailed information https://catalogues. ema. europa. eu/ (delete space for link)